Like, what was your reaction when you heard that?

That's very disconnected from reality.

Those people have not been on a deployment.

They have never had to live on a ship.

Um, so they don't know what it's like.

And, and I know that there's a lot of rhetoric around, "Well, this is what they signed up for," but I think it's important to, to mention that this is not a normal thing that is going on between the supply shortages and the consistent consecutive days at sea.

But there's, you know, there's a lot of rhetoric, too, from the administration about how mental health, how sailors are supposed to be tough, and if we talk about mental health, somehow there's a correlation between not being tough.

... that's, that's wild.

Right

... we see in children.

The most common is acute lymphoblastic leukemia, ALL.

And that treatment we have improved dramatically over the last, you know, 100 years.

I would say in the prior decade, children usually died of leukemia because of lack of supportive care, lack of transfusions, and lack of knowledge of what chemotherapy regimens were the best.

And nowadays, the great majority of children live long and lovely lives.

So the general treatment for ALL, so acute lymphoblastic leukemia, is intensive chemotherapy, combinations of medications that they get through a special IV line, and then in some cases, immunotherapies.

So talk to us a little bit about what advances have been made to understand the risk profile of the types of ALL.